drug
(citric acid + lactic acid + potassium bitartrate)
Marketedupdated 3mo agoby $EVFM Evofem Biosciences, Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 15, 2033
~6.6 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Mar 15, 2033method-of-use (U-1)US 10568855
- Mar 15, 2033method-of-use (U-1)US 11337989
- Mar 15, 2033compositionUS 11439610
- Mar 15, 2033method-of-use (U-1)US 11992472
News(0)
no news has mentioned this drug yet
Data sources
last refreshed just now
Found something off?
comments(0)
5-min edit window · permanent after that